Kiniksa Pharmaceuticals International, plc

NasdaqGS:KNSA Stock Report

Market Cap: US$1.5b

Kiniksa Pharmaceuticals International Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of KNSA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,3200.00943%
Individual Insiders3,526,4834.54%
VC/PE Firms5,876,5397.57%
Hedge Funds31,770,53940.9%
Institutions36,468,96647%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.


Top Shareholders

Top 25 shareholders own 93.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
44%
Baker Bros. Advisors LP
31,770,539US$654.2m0.36%6.61%
8.14%
Hillhouse Investment Management, Ltd.
5,876,539US$121.0m-21%1.11%
5.29%
BlackRock, Inc.
3,817,256US$78.6m-16.9%no data
4.57%
The Vanguard Group, Inc.
3,298,256US$67.9m10.6%no data
4.44%
Fairmount Funds Management LLC
3,204,841US$66.0m0%5.39%
4.01%
Braidwell LP
2,894,513US$59.6m40.6%2.71%
3.35%
Rubric Capital Management LP
2,419,103US$49.8m0%0.9%
2.38%
Sanj Patel
1,715,506US$35.3m0%no data
2.05%
Robert Desnick
1,478,505US$30.4m0%no data
1.67%
Pictet Asset Management Limited
1,207,749US$24.9m-7.36%0.02%
1.31%
Morgan Stanley, Investment Banking and Brokerage Investments
942,287US$19.4m-50.5%no data
1.05%
Parkman Healthcare Partners LLC
755,244US$15.6m16.7%2.18%
1.03%
Dimensional Fund Advisors LP
742,307US$15.3m11.8%no data
1.02%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
737,515US$15.2m-3.66%no data
1.01%
Driehaus Capital Management LLC
730,943US$15.1m18.7%0.09%
0.98%
State Street Global Advisors, Inc.
704,712US$14.5m-50.3%no data
0.97%
FMR LLC
696,766US$14.3m37,000%no data
0.9%
Rice Hall James & Associates, LLC
649,630US$13.4m8.16%0.72%
0.87%
Tang Capital Management, LLC
628,609US$12.9m0.53%0.97%
0.74%
ArrowMark Colorado Holdings, LLC
531,286US$10.9m-12.7%0.14%
0.72%
Millennium Management LLC
516,526US$10.6m-16.9%0.01%
0.7%
Granahan Investment Management, LLC
507,369US$10.4m-10.8%0.39%
0.67%
Geode Capital Management, LLC
482,976US$9.9m-43.1%no data
0.66%
Goldman Sachs Group, Investment Banking and Securities Investments
473,577US$9.8m0%no data
0.63%
HHLR Advisors, Ltd.
456,041US$9.4m0%0.13%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 06:18
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kiniksa Pharmaceuticals International, plc is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geoffrey MeachamBofA Global Research
Liisa BaykoEvercore ISI
Paul ChoiGoldman Sachs